檢索結果 - Silvia Geraci
- Showing 1 - 4 results of 4
-
1
Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis 由 Paul Harmatz, Federica Cattaneo, Diego Ardigò, Silvia Geraci, Julia B. Hennermann, Nathalie Guffon, Allan M. Lund, Christian J. Hendriksz, Line Borgwardt
出版 2018Artigo -
2
-
3
Efficacy and safety of Velmanase alfa in the treatment of patients with alpha‐mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double‐bl... 由 Line Borgwardt, Nathalie Guffon, Yasmina Amraoui, Christine í Dali, Linda De Meırleır, Mercedes Gil‐Campos, Bénédicte Héron, Silvia Geraci, Diego Ardigò, Federica Cattaneo, J. Fogh, J. M. Hannerieke Van den Hout, Michael Beck, Simon Jones, Anna Tylki‐Szymańska, Ulla Haugsted, Allan M. Lund
出版 2018Artigo -
4
Comprehensive long‐term efficacy and safety of recombinant human alpha‐mannosidase (velmanase alfa) treatment in patients with alpha‐mannosidosis 由 Allan M. Lund, Line Borgwardt, Federica Cattaneo, Diego Ardigò, Silvia Geraci, Mercedes Gil‐Campos, Linda De Meırleır, Cécile Laroche, Philippe Dolhem, Duncan Cole, Anna Tylki‐Szymańska, M. López Rodríguez, Encarna Guillén‐Navarro, Christine í Dali, Bénédicte Héron, J. Fogh, Nicole Muschol, Dawn Phillips, J. M. Hannerieke Van den Hout, Simon Jones, Yasmina Amraoui, Paul Harmatz, Nathalie Guffon
出版 2018Artigo
相關主題
Medicine
Alternative medicine
Internal medicine
Pathology
Placebo
Surgery
Alpha (finance)
Clinical trial
Construct validity
Gastroenterology
Patient satisfaction
Biochemistry
COPD
Chemistry
Chronic bronchitis
Clinical endpoint
Confidence interval
Disease
Enzyme replacement therapy
Gene
Immunology
Recombinant DNA
Relative risk
Sputum
Tuberculosis